Wearables in Clinical Practice: From Apple Watch to Continuous Glucose Monitors

Consumer wearables are now part of routine visits, but consumer-grade data is not the same thing as clinical-grade evidence. In this episode, we explain how to use wearable information without overcalling noise or inheriting risk you did not intend to accept.

Interpreting Consumer Wearable Data

• Start with context: symptom correlation, measurement timing, device type, and how the patient was wearing it
• Treat trend data as more useful than isolated spikes, especially for sleep, heart rate variability, and activity scores
• Apple Watch ECG can help with rhythm screening, but it is not a substitute for a diagnostic 12-lead ECG or clinician-interpreted ambulatory monitoring
• Ask whether the device output is validated for the condition being discussed instead of assuming every graph is actionable
• For continuous glucose monitors in non-diabetics, be careful: most fluctuations reflect normal physiology, meal timing, exercise, and sensor noise rather than disease

Liability and Escalation

The legal risk starts when clinicians casually review uploaded screenshots without a documented workflow. Once the data is considered, patients may reasonably assume it influenced medical decision-making.

• Create an intake rule for unsolicited wearable data: what staff collect, what gets uploaded, and what needs a scheduled review
• Document when data is patient-reported versus device-generated versus clinically verified
• Escalate to clinical-grade testing when wearable findings would change treatment, trigger urgent advice, or suggest a new diagnosis
• Avoid promising continuous surveillance unless your practice is actually monitoring the feed
• Give patients clear guidance on when wearable alerts should lead to urgent care versus routine follow-up

Billing for Remote Monitoring

RPM billing only works when the workflow is structured, documented, and based on qualifying devices and services. Many practices overestimate what counts.

• Confirm whether the device and data pathway meet RPM requirements before billing 99453 through 99458
• Track setup, education, transmission days, and time spent reviewing and communicating with the patient
• Distinguish casual in-visit interpretation from a true ongoing monitoring program
• Use wearable discussions to improve care, but do not let billing drive clinical judgment

Wearables can add signal, but only when clinicians control the interpretation framework instead of inheriting the device manufacturer's marketing claims.